Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Neoplasm Metastasis 4Neoplasms 3Lung Neoplasms 3Carcinoma 2Triple Negative Breast Neoplasms 1Recurrence 1Head and Neck Neoplasms 1Advanced Malignant Solid Tumors 1

Interventions

vorolanib 3neratinib 3dacomitinib 1Vinorelbine 1TAK-243 1Premedication 1Paclitaxel 1Clinical Trials, Phase II as Topic 1Capecitabine 11-(4-(4-(3-oxa-8-azabicyclo(3.2.1)octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Malignant Solid Tumors × dacomitinib × Clear all
NCT00728468 2017-08-02

A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients

Pfizer

Phase 1 Completed
16 enrolled 19 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡